357 related articles for article (PubMed ID: 23948879)
21. Evaluation of selenium, redox status and their association with plasma amyloid/tau in Alzheimer's disease.
Krishnan S; Rani P
Biol Trace Elem Res; 2014 May; 158(2):158-65. PubMed ID: 24682919
[TBL] [Abstract][Full Text] [Related]
22. Glial fibrillary acidic protein and protein S-100B: different concentration pattern of glial proteins in cerebrospinal fluid of patients with Alzheimer's disease and Creutzfeldt-Jakob disease.
Jesse S; Steinacker P; Cepek L; von Arnim CA; Tumani H; Lehnert S; Kretzschmar HA; Baier M; Otto M
J Alzheimers Dis; 2009; 17(3):541-51. PubMed ID: 19433893
[TBL] [Abstract][Full Text] [Related]
23. Progranulin and Amyloid-β Levels: Relationship to Neuropsychology in Frontotemporal and Alzheimer's Disease.
Körtvélyessy P; Gukasjan A; Sweeney-Reed CM; Heinze HJ; Thurner L; Bittner DM
J Alzheimers Dis; 2015; 46(2):375-80. PubMed ID: 25777512
[TBL] [Abstract][Full Text] [Related]
24. Associations of Neprilysin Activity in CSF with Biomarkers for Alzheimer's Disease.
Grimmer T; Goldhardt O; Yakushev I; Ortner M; Sorg C; Diehl-Schmid J; Förstl H; Kurz A; Perneczky R; Miners S
Neurodegener Dis; 2019; 19(1):43-50. PubMed ID: 31266021
[TBL] [Abstract][Full Text] [Related]
25. Anomalously phosphorylated tau and Abeta fragments in the CSF correlates with cognitive impairment in MCI subjects.
Maccioni RB; Lavados M; Guillón M; Mujica C; Bosch R; Farías G; Fuentes P
Neurobiol Aging; 2006 Feb; 27(2):237-44. PubMed ID: 16399209
[TBL] [Abstract][Full Text] [Related]
26. Overlap between frontotemporal dementia and Alzheimer's disease: cerebrospinal fluid pattern and neuroimaging study.
Padovani A; Premi E; Pilotto A; Gazzina S; Cosseddu M; Archetti S; Cancelli V; Paghera B; Borroni B
J Alzheimers Dis; 2013; 36(1):49-55. PubMed ID: 23568100
[TBL] [Abstract][Full Text] [Related]
27. Cerebrospinal fluid tau and beta-amyloid in Alzheimer patients, disease controls and an age-matched random sample.
Ibach B; Binder H; Dragon M; Poljansky S; Haen E; Schmitz E; Koch H; Putzhammer A; Kluenemann H; Wieland W; Hajak G
Neurobiol Aging; 2006 Sep; 27(9):1202-11. PubMed ID: 16085339
[TBL] [Abstract][Full Text] [Related]
28. TAU haplotype and the Saitohin Q7R gene polymorphism do not influence CSF Tau in Alzheimer's disease and are not associated with frontotemporal dementia or Parkinson's disease.
Johansson A; Zetterberg H; Håkansson A; Nissbrandt H; Blennow K
Neurodegener Dis; 2005; 2(1):28-35. PubMed ID: 16909000
[TBL] [Abstract][Full Text] [Related]
29. Cerebrospinal fluid biomarkers for Alzheimer’s disease: diagnostic performance in a homogeneous mono-center population.
Johansson P; Mattsson N; Hansson O; Wallin A; Johansson JO; Andreasson U; Zetterberg H; Blennow K; Svensson J
J Alzheimers Dis; 2011; 24(3):537-46. PubMed ID: 21297262
[TBL] [Abstract][Full Text] [Related]
30. Discriminatory and predictive capabilities of enzyme-linked immunosorbent assay and multiplex platforms in a longitudinal Alzheimer's disease study.
Jongbloed W; Kester MI; van der Flier WM; Veerhuis R; Scheltens P; Blankenstein MA; Teunissen CE
Alzheimers Dement; 2013 May; 9(3):276-83. PubMed ID: 23110867
[TBL] [Abstract][Full Text] [Related]
31. Does Caffeine Consumption Modify Cerebrospinal Fluid Amyloid-β Levels in Patients with Alzheimer's Disease?
Travassos M; Santana I; Baldeiras I; Tsolaki M; Gkatzima O; Sermin G; Yener GG; Simonsen A; Hasselbalch SG; Kapaki E; Mara B; Cunha RA; Agostinho P; Blennow K; Zetterberg H; Mendes VM; Manadas B; de Mendon A
J Alzheimers Dis; 2015; 47(4):1069-78. PubMed ID: 26401784
[TBL] [Abstract][Full Text] [Related]
32. CSF soluble amyloid precursor proteins in the diagnosis of incipient Alzheimer disease.
Perneczky R; Tsolakidou A; Arnold A; Diehl-Schmid J; Grimmer T; Förstl H; Kurz A; Alexopoulos P
Neurology; 2011 Jul; 77(1):35-8. PubMed ID: 21700579
[TBL] [Abstract][Full Text] [Related]
33. Neuropsychological and behavioural correlates of CSF biomarkers in dementia.
Engelborghs S; Maertens K; Vloeberghs E; Aerts T; Somers N; Mariën P; De Deyn PP
Neurochem Int; 2006 Mar; 48(4):286-95. PubMed ID: 16434124
[TBL] [Abstract][Full Text] [Related]
34. Cerebrospinal fluid biomarkers in the differential diagnosis of Alzheimer's disease from other cortical dementias.
de Souza LC; Lamari F; Belliard S; Jardel C; Houillier C; De Paz R; Dubois B; Sarazin M
J Neurol Neurosurg Psychiatry; 2011 Mar; 82(3):240-6. PubMed ID: 20802215
[TBL] [Abstract][Full Text] [Related]
35. Beta-amyloid peptides in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease.
Wiltfang J; Esselmann H; Smirnov A; Bibl M; Cepek L; Steinacker P; Mollenhauer B; Buerger K; Hampel H; Paul S; Neumann M; Maler M; Zerr I; Kornhuber J; Kretzschmar HA; Poser S; Otto M
Ann Neurol; 2003 Aug; 54(2):263-7. PubMed ID: 12891683
[TBL] [Abstract][Full Text] [Related]
36. Comparison of two analytical platforms for the clinical qualification of Alzheimer's disease biomarkers in pathologically-confirmed dementia.
Le Bastard N; Coart E; Vanderstichele H; Vanmechelen E; Martin JJ; Engelborghs S
J Alzheimers Dis; 2013; 33(1):117-31. PubMed ID: 22936010
[TBL] [Abstract][Full Text] [Related]
37. Highly increased CSF tau protein and decreased beta-amyloid (1-42) in sporadic CJD: a discrimination from Alzheimer's disease?
Kapaki E; Kilidireas K; Paraskevas GP; Michalopoulou M; Patsouris E
J Neurol Neurosurg Psychiatry; 2001 Sep; 71(3):401-3. PubMed ID: 11511720
[TBL] [Abstract][Full Text] [Related]
38. Cerebrospinal fluid biomarkers and memory present distinct associations along the continuum from healthy subjects to AD patients.
Rami L; Fortea J; Bosch B; Solé-Padullés C; Lladó A; Iranzo A; Sánchez-Valle R; Molinuevo JL
J Alzheimers Dis; 2011; 23(2):319-26. PubMed ID: 21098971
[TBL] [Abstract][Full Text] [Related]
39. PSEN1 mutation carriers present lower cerebrospinal fluid amyoid-β42 levels than sporadic early-onset Alzheimer's disease patients but no differences in neuronal injury biomarkers.
Balasa M; Vidal-Piñeiro D; Lladó A; Antonell A; Bosch B; Castellanos F; Bargalló N; Bartres-Faz D; Molinuevo JL; Sánchez-Valle R
J Alzheimers Dis; 2012; 30(3):605-16. PubMed ID: 22426017
[TBL] [Abstract][Full Text] [Related]
40. Upregulation and expression patterns of the angiogenic transcription factor ets-1 in Alzheimer's disease brain.
Jantaratnotai N; Ling A; Cheng J; Schwab C; McGeer PL; McLarnon JG
J Alzheimers Dis; 2013; 37(2):367-77. PubMed ID: 23948889
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
